Aspen Pharma of South Africa to Expand in China via Partnerships
November 27, 2017 -- Aspen Pharmacare Holdings, a South African generic drug company, plans to establish partnerships to build its China drug portfolio, according to management. The company established a China presence by acquiring anesthetic and thrombosis drugs from AstraZeneca and GlaxoSmithKline in 2016. With 650 staff, China is now Aspen's largest regional office. It has opened "key" sales offices in Beijing, Shanghai and Guangzhou, and is now ready to expand, the company said.